研究文章
最近的趋势在儿科患者的甲状腺结节的临床病理学特征:一个三级中心经验超过25年
|
|
0到10 (n= 24) |
11到15 (n= 79) |
16 - 18日n= 112) |
价值 |
|
| 年龄、年(意思是,SD) |
8 |
±2.358 |
14 |
±1.300 |
17 |
±0.833 |
|
| 性 |
|
|
|
|
|
|
0.002 |
| 女性 |
12 |
50.0% |
61年 |
77.2% |
93年 |
83.0% |
|
| 男性 |
12 |
50.0% |
18 |
22.8% |
19 |
17.0% |
|
| 期诊断 |
|
|
|
|
|
|
0.892 |
| 1990 - 1995 |
4 |
16.7% |
17 |
21.5% |
21 |
18.8% |
|
| 1996 - 2000 |
8 |
33.3% |
16 |
20.3% |
26 |
23.2% |
|
| 2001 - 2005 |
4 |
16.7% |
12 |
15.2% |
24 |
21.4% |
|
| 2006 - 2010 |
3 |
12.5% |
16 |
20.3% |
19 |
17.0% |
|
| 2011 - 2014 |
5 |
20.8% |
18 |
22.8% |
22 |
19.6% |
|
| 主诉导致住院 |
|
|
|
|
|
|
0.197 |
| Incidentaloma |
3 |
12.5% |
6 |
7.6% |
12 |
10.7% |
|
| 前脖子上明显的质量 |
18 |
75.0% |
61年 |
77.2% |
86年 |
76.8% |
|
| 侧颈部明显的质量 |
2 |
8.3% |
4 |
5.1% |
1 |
0.9% |
|
| 脖子不舒服 |
0 |
|
2 |
2.5% |
1 |
0.9% |
|
| 声音沙哑 |
0 |
|
2 |
2.5% |
0 |
|
|
| 呼吸困难 |
1 |
4.2% |
1 |
1.3% |
1 |
0.9% |
|
| 未知的 |
0 |
|
3 |
3.8% |
11 |
9.8% |
|
| 细针吸活组织录取 |
|
|
|
|
|
|
0.008 |
| 是的 |
20. |
83.3% |
67年 |
84.8% |
74年 |
66.1% |
|
| 没有 |
4 |
16.7% |
12 |
15.2% |
38 |
33.9% |
|
| 最初的细胞学 |
|
|
|
|
|
|
0.013 |
| Nondiagnostic或不满意 |
1 |
5.0% |
0 |
|
0 |
|
|
| 良性的 |
5 |
25.0% |
8 |
11.9% |
10 |
13.5% |
|
| 异型性待定意义或滤泡损伤待定的意义 |
2 |
10.0% |
7 |
10.4% |
6 |
8.1% |
|
| 滤泡性肿瘤或滤泡性肿瘤的怀疑 |
2 |
10.0% |
8 |
11.9% |
7 |
9.5% |
|
| 怀疑恶性肿瘤 |
4 |
20.0% |
5 |
7.5% |
2 |
2.7% |
|
| 恶性 |
6 |
30.0% |
38 |
56.7% |
48 |
64.9% |
|
| 其他(神经鞘瘤和脓肿) |
0 |
|
1 |
1.5% |
1 |
1.4% |
|
| 最后病理甲状腺切除术后 |
|
|
|
|
|
|
0.291 |
| 良性的 |
12 |
50.0% |
27 |
34.2% |
48 |
42.9% |
|
| 甲状腺机能亢进(弥漫性增生) |
0 |
|
7 |
25.9% |
30. |
62.5% |
|
| 腺瘤甲状腺肿/结节性增生 |
6 |
50.0% |
11 |
40.7% |
9 |
18.8% |
|
| 桥本甲状腺炎 |
0 |
|
0 |
|
2 |
4.2% |
|
| 滤泡腺瘤 |
4 |
33.3% |
7 |
25.9% |
7 |
14.6% |
|
| 许特耳氏细胞腺瘤 |
1 |
8.3% |
1 |
3.7% |
0 |
|
|
| 其他(神经鞘瘤和脓肿) |
1 |
8.3% |
1 |
3.7% |
0 |
|
|
| 恶性 |
12 |
50.0% |
52 |
65.8% |
64年 |
57.1% |
|
| 乳头状甲状腺癌 |
9 |
75.0% |
43 |
82.7% |
54 |
84.4% |
|
| 滤泡性甲状腺癌 |
3 |
25.0% |
8 |
15.4% |
10 |
15.6% |
|
| 滤泡性甲状腺癌乳头状 |
0 |
|
1 |
1.9% |
0 |
|
|
| 由甲状腺切除术后病理肿瘤大小(厘米) |
2.6 |
(1.2 - -6.5) |
2.5 |
(0.5 - -8.5) |
2.6 |
(0.4 - -9.0) |
0.587 |
|
|
